Physician

Ahmed Bilal Sheikh, MD

According to 2025 Medicare claims, Ahmed Sheikh, MD (NPI: 1942655568) practices ophthalmology in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is MILLER OPHTHALMOLOGY ASSOCIATES LLC (NPI: 1629024245; TIN: 22-3561332) and primary practice location at 07981-1047.

Sheikh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 95 traditional Medicare patients, billed 274 HCPCS/CPT codes, and received $33,510 in Medicare payments. The top billing code was 68840 (Probing of nasal tear duct). Part D data shows 83 prescription claims across 55 beneficiaries totaling $1,779 in drug costs, led by Erythromycin (Erythromycin Base). Open Payments data shows 3 records totaling $85. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $10,799 to $1,779. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$17K$34K2021 Medicare payment: $7,052 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $23,998 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $15,221 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $33,510 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202152175$7,052
2022123610$23,998
202379212$15,221
202495274$33,510

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$53K2017 Drug cost: $10,799 (USD; Tot_Drug_Cst)2018 Drug cost: $52,993 (USD; Tot_Drug_Cst)2019 Drug cost: $43,778 (USD; Tot_Drug_Cst)2020 Drug cost: $19,788 (USD; Tot_Drug_Cst)2021 Drug cost: $8,905 (USD; Tot_Drug_Cst)2022 Drug cost: $2,399 (USD; Tot_Drug_Cst)2023 Drug cost: $2,856 (USD; Tot_Drug_Cst)2024 Drug cost: $1,779 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201764194$10,799
2018183777$52,993
2019165697$43,778
202088298$19,788
2021147385$8,905
2022136182$2,399
20235777$2,856
20245583$1,779

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
68840Probing of nasal tear duct1213$135
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1921$110
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4758$76
92082Exam of visual field with intermediate testing1415$41
92285Photography of content of eyes5057$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErythromycinErythromycin Base49713$500
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11185$100

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$85Glaukos Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed Bilal Sheikh, MD?

Tedicare shows public-source Medicare data for Ahmed Bilal Sheikh, MD (NPI 1942655568), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Bilal Sheikh, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmed Bilal Sheikh, MD?

Ahmed Bilal Sheikh, MD is linked to MILLER OPHTHALMOLOGY ASSOCIATES LLC (billing NPI 1629024245) in the available physician profile data.

Does Ahmed Bilal Sheikh, MD have Open Payments data?

Ahmed Bilal Sheikh, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.